These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2478766)

  • 1. Responsiveness of peripheral veins to transdermal and sublingual nitroglycerin in healthy male volunteers.
    Hiremath AN; Hoffman BB; Blaschke TF
    J Cardiovasc Pharmacol; 1989 Oct; 14(4):534-41. PubMed ID: 2478766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous versus intermittent nitroglycerin administration in experimental heart failure: vascular relaxation and radioligand binding to adrenoceptors and ion channels.
    Bauer JA; Fung HL; Zheng W; Kwon YW; Gopalakrishnan M; Triggle DJ
    J Cardiovasc Pharmacol; 1993 Oct; 22(4):600-8. PubMed ID: 7505363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventive effects of angiotensin-converting enzyme inhibitors on nitrate tolerance during continuous transdermal application of nitroglycerin in patients with chronic heart failure.
    Watanabe H; Kakihana M; Ohtsuka S; Sugishita Y
    Jpn Circ J; 1998 May; 62(5):353-8. PubMed ID: 9626903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical, hemodynamic, and vascular evidence concerning the free radical hypothesis of nitrate tolerance.
    Milone SD; Pace-Asciak CR; Reynaud D; Azevedo ER; Newton GE; Parker JD
    J Cardiovasc Pharmacol; 1999 May; 33(5):685-90. PubMed ID: 10226853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal nitroglycerin in angina pectoris.
    Abrams J
    Eur Heart J; 1989 May; 10 Suppl A():11-9. PubMed ID: 2501090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intermittent transdermal nitroglycerin on occurrence of ischemia after patch removal: results of the second transdermal intermittent dosing evaluation study (TIDES-II).
    Pepine CJ; Lopez LM; Bell DM; Handberg-Thurmond EM; Marks RG; McGorray S
    J Am Coll Cardiol; 1997 Oct; 30(4):955-61. PubMed ID: 9316524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ointments and transdermal nitroglycerin patches for stable angina pectoris.
    Thadani U; Lipicky RJ
    Cardiovasc Drugs Ther; 1994 Aug; 8(4):625-33. PubMed ID: 7848897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antianginal effects of nitroglycerin patches.
    Reichek N; Priest C; Zimrin D; Chandler T; Sutton MS
    Am J Cardiol; 1984 Jul; 54(1):1-7. PubMed ID: 6430053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of vascular nitroglycerin tolerance by inhibition of protein kinase C.
    Zierhut W; Ball HA
    Br J Pharmacol; 1996 Sep; 119(1):3-5. PubMed ID: 8872349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and rebound phenomenon related to intermittent nitroglycerin therapy for the prevention of nitrate tolerance.
    Watanabe H; Kakihana M; Ohtsuka S; Sugishita Y
    Jpn Circ J; 1998 Aug; 62(8):571-5. PubMed ID: 9741733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional and systemic hemodynamic and humoral effects of transdermal nitroglycerin in mild hypertension.
    Pedrinelli R; Graziadei L; Panarace G; Duranti P; Motolese M; Salvetti A
    J Cardiovasc Pharmacol; 1989 Oct; 14(4):636-41. PubMed ID: 2478778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic attenuation and the nitrate-free interval: alternative dosing strategies for transdermal nitroglycerin.
    Flaherty JT
    Am J Cardiol; 1985 Dec; 56(17):32I-37I. PubMed ID: 3000161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The noninvasive quantitative evaluation of the acute hemodynamic effects of sublingual and transdermal nitroglycerin in man].
    Pizzetti F; Peci P; Manni B; Bonaglia M; Ghio S; Latini R; Avanzini F
    G Ital Cardiol; 1993 Apr; 23(4):327-34. PubMed ID: 8319860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of sublingual nitroglycerin in patients receiving transdermal nitroglycerin for coronary artery disease: prevention of cross-tolerance.
    Naito H; Matsuda Y; Yorozu T; Shiomi K; Maeda T; Seki K; Tada T; Fujii H
    Clin Cardiol; 1991 Aug; 14(8):644-50. PubMed ID: 1914267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitroglycerin-induced relaxation of anorectal smooth muscle: evidence for apparent lack of tolerance development in the anaesthetized rat.
    Wang EQ; Soda DM; Fung HL
    Br J Pharmacol; 2001 Sep; 134(2):418-24. PubMed ID: 11564661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between nitroglycerin-induced vascular relaxation and nitric oxide production. Probes with inhibitors and tolerance development.
    Chung SJ; Fung HL
    Biochem Pharmacol; 1993 Jan; 45(1):157-63. PubMed ID: 8424809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitroglycerin in chronic stable angina pectoris.
    Reichek N
    Am J Cardiol; 1987 Nov; 60(15):15H-17H. PubMed ID: 3120561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal nitroglycerin (glyceryl trinitrate). A review of its pharmacology and therapeutic use.
    Todd PA; Goa KL; Langtry HD
    Drugs; 1990 Dec; 40(6):880-902. PubMed ID: 2127741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid development of nitrate tolerance in healthy volunteers: assessment using spectral analysis of short-term blood pressure and heart rate variability.
    Cloarec-Blanchard L; Funck-Brentano C; Carayon A; Jaillon P
    J Cardiovasc Pharmacol; 1994 Aug; 24(2):266-73. PubMed ID: 7526059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitroglycerin induces late preconditioning against myocardial infarction in conscious rabbits despite development of nitrate tolerance.
    Hill M; Takano H; Tang XL; Kodani E; Shirk G; Bolli R
    Circulation; 2001 Aug; 104(6):694-9. PubMed ID: 11489777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.